Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
or aggravate the development of intestinal and respiratory diseases such as chronic intestinal colitis and fibrosis, asthma, pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD
-
of myocardial fibrosis using 68Ga-FAPI-04 PET/CT (Protein Positron Emission Tomography associated with Computed Tomography using Gallium-68-labeled Fibroblast Activation Inhibitor), integrating multimodal imaging
-
projects aimed at uncovering the molecular and cellular mechanisms driving fibrosis and metabolic disease. The Romeo group works at the intersection of genetics, metabolism, and clinical medicine. We combine
-
Social Worker - Cystic Fibrosis Clinic. WORK SCHEDULE Part-Time / 32 hours per week Day Shifts (Monday/Thursday on-site and 2 day telework) This position is expected to last through 6/30/2026 to be renewed
-
fibrosis patients. Working at a Level 1 Trauma Center means no two days are the same! RTs will care for trauma patients, cardiac arrests and high acuity admissions. You will accompany patients
-
the tumor microenvironment by reducing fibrosis, inflammation and immune suppression. The responsibilities of this position will be to analyze RNAseq data, immunohistochemistry and breed transgenic mouse
-
: Applications accepted all year round Details Breast and pancreatic tumours are characterised by excessive deposition of extracellular matrix (ECM) components, resulting in extensive fibrosis, which in turn
-
visit: https://ucnet.universityofcalifornia.edu/compensation-and-benefits/index.html Required Qualifications This position requires flexibility to orient and work at all UCSF Medical Center locations and
-
. The salary range for this position is $30.80 - $45.80 (Hourly Rate). To learn more about the benefits of working at UCSF, including total compensation, please visit: https://ucnet.universityofcalifornia.edu
-
University of Texas Health Science Center San Antonio | San Antonio, Texas | United States | about 1 hour ago
on our existing strengths in diabetes, acute kidney injury, aging, cardio-renal disease, fibrosis, and genetic basis of kidney disease to become national leaders in basic, translational, and clinical